Second Quarter 2009 Results

• To print this page, please use the File menu or press simultaneously ctrl + p keys.
• Send this page

July 29, 2009

The Second Quarter 2009 Results were reviewed by the management during a conference call.

The successive speakers were:

• Mr. Christopher A. Viehbacher, Chief Executive Officer
• Mr. Hanspeter Spek, Executive VP, Pharmaceutical Operations
• Mr. Jérôme Contamine, Executive VP, Chief Financial Officer

The presentation was followed by a Q&A session.
 

Interview with Christopher A. Viehbacher

Access the video

Audio webcast on July 29

Access the recorded webcast

Podcasts

Introduction - Sébastien Martel Q2 2009 Results - Christopher A. Viehbacher Q2 2009 Results - Hanspeter Spek Q2 2009 Results - Jérôme Contamine Update on Transforming - Christopher A. Viehbacher Update on Transforming - Jérôme Contamine Concluding Remarks - Christopher A. Viehbacher Q&A session

Download documents

Press release on Second Quarter 2009 Results Presentation "Second Quarter 2009 Results"